Related references
Note: Only part of the references are listed.The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders
Makoto Taniguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
Xiao-yan Yang et al.
CANCER LETTERS (2013)
Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance
David J. Pinato et al.
CANCER TREATMENT REVIEWS (2013)
DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells
Teka-Ann S. Haynes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Gene and doxorubicin co-delivery system for targeting therapy of glioma
Shuhuan Liu et al.
BIOMATERIALS (2012)
Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity
Lili Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
Donghua Liu et al.
MOLECULAR PHARMACEUTICS (2011)
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer
Mahavir Chougule et al.
LUNG CANCER (2011)
Palytoxins and cytoskeleton: An overview
M. Carmen Louzao et al.
TOXICON (2011)
Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems
Lilian E. van Vlerken et al.
AAPS JOURNAL (2010)
Metabolism of short-chain ceramide by human cancer cells-Implications for therapeutic approaches
Jacqueline V. Chapman et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors
Andrew V. Schally et al.
Current Drug Delivery (2010)
Potential Mechanisms Involved in Ceramide-induced Apoptosis in Human Colon Cancer HT29 Cells
Jing Wang et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2009)
Review of the Contemporary Cytotoxic and Biologic Combinations Available for the Treatment of Metastatic Breast Cancer
Katherine H. Rak Tkaczuk
CLINICAL THERAPEUTICS (2009)
A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel
Yang Yang et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin
Kenji Kono et al.
BIOMATERIALS (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancer
Ramon Colomer
EJC SUPPLEMENTS (2008)
L-Histidine-based pH-sensitive anticancer drug carrier micelle: Reconstitution and brief evaluation of its systemic toxicity
Kyung T. Oh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
The microfilament system and malignancy
Uno Lindberg et al.
SEMINARS IN CANCER BIOLOGY (2008)
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer
Jose R. Pereira et al.
LUNG CANCER (2007)
Recent advances in the immunobiology of ceramide
Saumya Pandey et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer
Lilian E. van Vlerken et al.
CANCER RESEARCH (2007)
Drug interactions in cancer therapy
Charity D. Scripture et al.
NATURE REVIEWS CANCER (2006)
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: A multicenter phase II study
P. Makrantonakis et al.
LUNG CANCER (2006)
Characterization of the activities of actin-affecting drugs on tumor cell migration
C Hayot et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (AsP26Glu) and less stable microtubules
M Hari et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Gemcitabine plus taxane combinations in metastatic breast cancer: a comprehensive review
R Colomer
EJC SUPPLEMENTS (2005)
Docetaxel for treatment of solid tumours: a systematic review of clinical data
A Montero et al.
LANCET ONCOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Molecular mechanisms of caspase regulation during apoptosis
SJ Riedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Microfilament actin remodeling as a potential target for cancer drug development
JY Rao et al.
CURRENT CANCER DRUG TARGETS (2004)
Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells
T Stover et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
JW Friedberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells
A Nehmé et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
